These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6943957)

  • 1. Thrombophlebitis in cancer patients.
    Wajima T
    Ann N Y Acad Sci; 1981; 370():138-44. PubMed ID: 6943957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are baseline prothrombin time/partial thromboplastin time values necessary before instituting anticoagulation?
    McKinley L; Wrenn K
    Ann Emerg Med; 1993 Apr; 22(4):697-702. PubMed ID: 8457098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
    Wheeler AP; Jaquiss RD; Newman JH
    Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin therapy. The effect of heparin on prothrombin times.
    Lutomski DM; Djuric PE; Draeger RW
    Arch Intern Med; 1987 Mar; 147(3):432-3. PubMed ID: 3827418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migratory thrombophlebitis. Heparin sodium vs. warfarin sodium therapy.
    Johnson AC; Kurtides ES
    IMJ Ill Med J; 1967 Jan; 131(1):54-6. PubMed ID: 4382849
    [No Abstract]   [Full Text] [Related]  

  • 8. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.
    Sack GH; Levin J; Bell WR
    Medicine (Baltimore); 1977 Jan; 56(1):1-37. PubMed ID: 834136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated coagulopathies and advanced malignancies.
    Fengler SA; Berenberg JL; Lee YT
    Am Surg; 1990 Jun; 56(6):335-8. PubMed ID: 2350105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in anticoagulant therapy.
    Litin SC; Gastineau DA
    Mayo Clin Proc; 1995 Mar; 70(3):266-72. PubMed ID: 7861815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
    Fareed J; Kumar A; Rock A; Walenga JM; Davis P
    Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study.
    Almazan A; Lozano F; Ramos M; Rodriguez-Moran M; Gomez-Alonso A
    Angiology; 1985 Jun; 36(6):363-9. PubMed ID: 4025944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.
    Groce JB; Gal P; Douglas JB; Steuterman MC
    Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusually prolonged case of heparin-induced thrombocytopenia and disseminated intravascular coagulation.
    Castaman G; Ruggeri M; Girardello R; Rodeghiero F
    Haematologica; 1992; 77(2):174-6. PubMed ID: 1398304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible induction dose regimen for warfarin and prediction of maintenance dose.
    Fennerty A; Dolben J; Thomas P; Backhouse G; Bentley DP; Campbell IA; Routledge PA
    Br Med J (Clin Res Ed); 1984 Apr; 288(6426):1268-70. PubMed ID: 6424820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory control of heparin and heparin fragment treatment: an experimental study.
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; De Sèze O; Toulemonde F
    Semin Thromb Hemost; 1989 Oct; 15(4):373-7. PubMed ID: 2554497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.